GLP Watchdog

Hers vs Polly

Hers has an open FDA warning letter dated September 9, 2025. Polly has none. On compounded semaglutide injection, Polly costs $240 less a year at standing rates: $179 a month against $199 a month at Hers.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hers / Polly

Hers logo

Hers

6.8/10

Polly logo

Polly

8.4/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$199/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
All 50 states
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked November 2026
Visit Hers
Visit Polly

Neither Hers nor Polly pays us. Links to them earn nothing. Scores: Hers 6.8, Polly 8.4. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Polly has none.

  2. 02

    Hers names three pharmacies. Polly names two pharmacies, all 503A.

  3. 03

    On compounded semaglutide injection, Polly costs $240 less a year at standing rates: $179 a month against $199 a month at Hers.

  4. 04

    Only Hers lists a price for brand-name tirzepatide pen. Only Polly lists a price for compounded tirzepatide injection.

  5. 05

    Hers states you can cancel at any time; Polly does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hers

Polly

Compounded semaglutide injection

$199/mo

$2,388 a year

$179/moLower

$2,148 a year

Compounded tirzepatide injection
Not sold or not priced

$279/mo

$3,348 a year

Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

Not sold or not priced
Price includes
Medication
Medication, clinician visits, shipping
Billed separately
Clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Not stated
Minimum term
None
Month to month, or a 3- or 6-month supply charged at checkout
Refunds
No refund guaranteed once the pharmacy has processed an order
Full refund only before the medical intake is submitted; 3- and 6-month plans cannot be refunded once the first month has passed
Early-exit fee
Not stated
Yes

Read off each seller’s own pages. Hers: September 28, 2026. Polly: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which Polly does not price
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

The case for Polly

8.4/10
  • No FDA warning letter on record
  • $240 a year less on compounded semaglutide injection
  • Sells compounded tirzepatide injection, which Hers does not price
  • Price includes clinician visits
Visit Polly

Scores

Hers 6.8 · Polly 8.4 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
5.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.0A
vs
B
10.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

3.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Hers vs Polly: questions

Hers has an open FDA warning letter dated September 9, 2025. Polly has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. Polly names two pharmacies, all 503A. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Polly, by $240 a year at standing rates. Hers: $199 a month, about $2,388 a year. Polly: $179 a month, about $2,148 a year.
Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order. Polly does not state its cancellation terms.
Neither Hers nor Polly pays us. Links to them earn nothing. Scores: Hers 6.8, Polly 8.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks